Cargando…

AML treatment in older adults

Detalles Bibliográficos
Autores principales:	Sehgal, Alison, Boyiadzis, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600619/ https://www.ncbi.nlm.nih.gov/pubmed/26420822

Ejemplares similares

Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
por: Hong, Chang-Sook, et al.
Publicado: (2021)

Biologically-active exosomes in plasma of AML patients inhibit innate immunity and promote leukemia progression
por: Boyiadzis, Michael, et al.
Publicado: (2015)

Autologous Transplantation for Older Adults with AML
por: Mueller, Beatrice U., et al.
Publicado: (2018)

Targeting glutamine uptake in AML
por: Jacque, Nathalie, et al.
Publicado: (2014)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Immunotherapy for acute leukemia
por: Boyiadzis, Michael, et al.
Publicado: (2015)

UCB HCT in FLT3+ AML
por: Ustun, Celalettin, et al.
Publicado: (2017)

Maintenance of elderly AML patients with androgens
por: Pigneux, Arnaud, et al.
Publicado: (2017)

In quest for leukemia initiating cells in AML
por: De Grandis, Maria, et al.
Publicado: (2018)

The Challenge of AML in Older Patients
por: Burnett, Alan K
Publicado: (2013)

HLX in AML: novel prognostic and therapeutic target
por: Pandolfi, Ashley, et al.
Publicado: (2012)

Phospholipid metabolism regulates AML growth and stemness
por: Xu, Mingjing, et al.
Publicado: (2019)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

Targeting cistrome and dysregulated transcriptome of post-MPN sAML
por: Verstovsek, Srdan, et al.
Publicado: (2017)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

Treatment of older adults with FLT3-mutated AML: Emerging paradigms and the role of frontline FLT3 inhibitors
por: Short, Nicholas J., et al.
Publicado: (2023)

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
por: Saliba, Antoine N., et al.
Publicado: (2022)

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
por: Freeman, Sylvie D., et al.
Publicado: (2023)

Coordinate PI3K pathway and Bcl-2 family disruption in AML
por: Bose, Prithviraj, et al.
Publicado: (2012)

The ubiquitin-activating enzyme, UBA1, as a novel therapeutic target for AML
por: Barghout, Samir H., et al.
Publicado: (2018)

Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
por: Jacoby, Meagan A., et al.
Publicado: (2021)

Bridging Strategies to Allogeneic Transplant for Older AML Patients
por: Hecker, Judith, et al.
Publicado: (2018)

Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
por: Kubasch, Anne Sophie, et al.
Publicado: (2018)

Glioblastoma in older adults
por: Holdhoff, Matthias, et al.
Publicado: (2018)

Sarcopenia in Older Adults
por: Scott, David
Publicado: (2019)

Vaccinations for older adults
por: Barratt, Jane
Publicado: (2022)

Treatments for children and adolescents with AML
por: Kim, Hyery
Publicado: (2020)

An intensive approach to treatment for older patients with relapsed isolated NPM1 mutated AML
por: Dukka, Srivasavi, et al.
Publicado: (2015)

How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML
por: Kim, Hee-Je
Publicado: (2014)

Benzodiazepine and antipsychotic medication use in older adults
por: Neft, Michael W., et al.
Publicado: (2019)

Clinical Results of Hypomethylating Agents in AML Treatment
por: Cruijsen, Marjan, et al.
Publicado: (2014)

COVID-19 and Older Adult
por: Morley, John E., et al.
Publicado: (2020)

Dynamic changes in physical function during intensive chemotherapy affect transplant outcomes in older adults with AML
por: Min, Gi-June, et al.
Publicado: (2023)

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
por: Short, Nicholas J., et al.
Publicado: (2023)

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
por: Klempnauer, Karl-Heinz
Publicado: (2023)

Head and Neck Issues in Older Adults
por: Madden, Kenneth M.
Publicado: (2014)

Physical activity, CVD, and older adults
por: Ferraro, Richard A., et al.
Publicado: (2019)

Exercise Evaluation and Prescription in Older Adults
por: Furtado, Guilherme Eustáquio, et al.
Publicado: (2022)

Learning by motor imagery in older adults
por: Saimpont, Arnaud, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3iolm7gvpa4b75lsoqqjmhau8j